Links between Pharmaceutical R&D Models and Access to Affordable Medicines

B Godman, W Oortwijn, Chiara De Waure, I Mosca, Anna Puggina, Maria Lucia Specchia, Paolo Campanella, J. Van Der Tuin

Risultato della ricerca: LibroBook


Each patient in the European Union has a right of access to care. National governments face the challenge to balance resources against healthcare demand to ensure that populations enjoy equitable access to effective, affordable and sustainable healthcare. This study describes the main challenges with regard to access to affordable medicines, including Research & Development, pricing and reimbursement of medicines and the influence of the economic crisis. Potential policy options to tackle these challenges are presented, drawing on best practices and a review of specific measures implemented in different European countries. This document was provided by Policy Department A for the Committee on the Environment, Public Health and Food Safety.
Lingua originaleEnglish
EditoreEuropean Parliament
Numero di pagine164
ISBN (stampa)978-92-846-0181-3
Stato di pubblicazionePubblicato - 2016


  • Access
  • Affordable Medicines


Entra nei temi di ricerca di 'Links between Pharmaceutical R&D Models and Access to Affordable Medicines'. Insieme formano una fingerprint unica.

Cita questo